Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.
about
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Non-invasive prediction of forthcoming cirrhosis-related complications.Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Non-invasive diagnosis of advanced fibrosis and cirrhosis.Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection.The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test.Low serum hyaluronic acid levels associated with spontaneous HBsAg clearance.Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study.What physicians should know about the management of chronic hepatitis B in children: East side story.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting.Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B.Advances in the treatment of portal hypertension in cirrhosis.Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis.ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity.Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis.Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea.The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels.Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis.
P2860
Q26777511-795A4147-C65E-45C5-BC64-E0AD578755B9Q27000645-35593418-3AF9-46E1-B83D-1C40564DE014Q30397191-D710E13B-6445-4D7C-B25F-758178914C5FQ30423320-6B76E53C-0E8E-4C33-BF92-55AB08125EE9Q34532528-636E944C-39D8-4B41-A46F-C44EFC3A35ECQ34981143-B7505DB7-13E8-4B19-A99A-1DFAC2FA7071Q35149314-CBA49AEB-8FA6-4F76-B757-A4D1A1DEFF9EQ35194722-FB7C8921-D514-4F2B-AFD8-95E7BE117A5EQ35594244-F76321CE-3697-4A6C-B192-404AEA945D74Q35695535-ED27A736-B319-4A91-9333-0E61DC61F9DCQ36167463-EC606B12-020A-43B2-8C80-030C5792E2C6Q36654566-B6552F8E-A45D-4E6B-8BFD-0D7FB46CFA8EQ37570946-0BDD73F1-8F51-4B91-8000-A527E9A0DBE3Q37682515-6DC44B7B-2B9B-4146-8ACB-CA2F682C8A91Q38188809-C7BAF5FD-8A45-49FE-A97F-106BB4FF759CQ38598029-8291C131-024D-4C18-8A4A-C1BC5436C893Q38669857-5E109B07-E513-488D-9E91-FA9F3CDE0770Q38776991-70A1BD26-83B1-4A23-B869-4C5F15439A26Q40915287-7A669968-F99E-48C7-918A-D14C878496DAQ42177206-D25D1581-DFA6-4BCA-BCB3-E385B43CEC6BQ42198890-12603AA5-454C-4913-9863-3D33D6A9B74BQ42355009-3FDA4AD5-F61F-4030-9406-06836E811908Q44402583-7E1B38AB-E918-44A3-A1B5-71C34F756861Q44663535-0656BDD9-DD90-43DE-982F-24449CC5BD7AQ46485907-498300FC-51AA-4A3E-B4AD-B75FEF52B7D9Q47101834-BD81A312-2412-4259-8DE7-FB5208772CCCQ47630903-5FF4FD95-5130-4842-B413-73CA4EF598DFQ48155717-9CE1FB58-9AC0-4684-89B8-912FCD1F9576Q54247048-95718169-4D01-454D-B20F-999FC07646DEQ55353688-638A3167-48B0-49F7-8BC5-014026EA1DE0Q55376294-145F99F9-4A5D-42BD-992D-6341D5BB068DQ55438231-AD60E981-E4C1-4344-816B-6C495A852076
P2860
Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prospective validation of ELF ...... ects with chronic hepatitis B.
@ast
Prospective validation of ELF ...... ects with chronic hepatitis B.
@en
Prospective validation of ELF ...... ects with chronic hepatitis B.
@nl
type
label
Prospective validation of ELF ...... ects with chronic hepatitis B.
@ast
Prospective validation of ELF ...... ects with chronic hepatitis B.
@en
Prospective validation of ELF ...... ects with chronic hepatitis B.
@nl
prefLabel
Prospective validation of ELF ...... ects with chronic hepatitis B.
@ast
Prospective validation of ELF ...... ects with chronic hepatitis B.
@en
Prospective validation of ELF ...... ects with chronic hepatitis B.
@nl
P2093
P2860
P1433
P1476
Prospective validation of ELF ...... jects with chronic hepatitis B
@en
P2093
Beom Kyung Kim
Chae Yoon Chon
Do Young Kim
Hyon Suk Kim
Jun Yong Park
Seung Up Kim
Young Nyun Park
P2860
P304
P356
10.1371/JOURNAL.PONE.0041964
P407
P577
2012-07-27T00:00:00Z